Because filing requires proof of use and a diagnosis consistent with the alleged severe side effect, it is generally advisable to consult an attorney to evaluate the facts of your case and preserve deadlines as the number of filings continues to increase
In the Phase 2 obesity trial published in NEJM in 2023, retatrutide at the 12 mg weekly dose produced a mean placebo-adjusted body weight reduction of 22.1 percentage points (22.1% (24.2% arm) mean absolute reduction on the retatrutide arm) at 48 weeks (Jastreboff et al., NEJM, 2023)
Carefully follow your doctor's recommendations , including reading the medication guide and using semaglutide as prescribed
How Tirzepatide Supports Weight Loss Appetite Suppression : By activating GLP-1 and GIP receptors, tirzepatide reduces hunger and food intake
Many patients experience significant appetite suppression, which can inadvertently lead to insufficient protein, vitamin, and mineral consumption if not carefully managed